About Abnova

  • Where to buy
  • Choose your location

News

Read more articles in year   2021   2020   2019   2018   2017   2016   2015   2014   2013   2012   2011   2010   2009   2008   2007
 
2019/12/19 Press Release: Abnova Upgrades its Antibody Technology and Manufacturing for Researchers, Biotech and Pharmaceutical Customers Worldwide
2019/12/12 Conference: Invited Talk at Investor Conference
2019/11/27 Conference: Invited Talk at E-Da Hospital
2019/11/15 Conference: Invited Talk at Taiwan Adventist Hospital
2019/11/13 Press Release: Abnova Integrates CARlike-IL12 Technology and Setup a IL-12 Patent Portfolio Strategy for Gene Modified T cell Therapy
2019/11/08 Conference: Invited Talk at En Chu Kong Hospital
2019/10/29 Press Release: Abnova’s mutaFISH™ Probes Energize the Fluorescent In Situ Hybridization Global Market and Propel New Precision Medicine Applications
2019/10/28 Conference: がん研究ツール最前線2019
2019/10/11 Conference: 第9回がん新薬開発合同シンポジウム がん治療の未来戦略
2019/09/23 Press Release: Abnova Subsidiary Wellconn Genomics™ Clinical Laboratory Introduces Germline Genetic Testing Service for Prostate Cancer Hereditary Predisposing Genes
2019/08/26 Press Release: Abnova Completes GMP Manufacturing Agreements and Appoints Aldevron and Lentigen to Manufacture the Respective Transfer Plasmid and Lentiviral Vector for its Gene-Modified T Cell
2019/05/28 Press Release: Abnova & National Cancer Center Hospital East Japan Collaborate to Setup Decentralized, Point-of-Care, IL-12 Gene Modified T Cell Manufacturing for Cancer Therapy
2019/05/06 Press Release: Abnova Introduces LiquidCell™ Negative Enrichment Circulating Tumor Cell Platform for the Clinical Pathology Market
2019/03/18 Press Release: Abnova Expands its Patent Repertoire of T Cell Therapy Against Solid Tumors
2019/01/28 Press Release: Abnova & Nippon Kayaku Signed Exclusive ACTN4 Supply and Commercialization Agreement for Lung Cancer IVD Market in Japan
 
  • RSS
  • YouTube
  • Linkedin
  • Facebook